Some critics fear Novo Nordisk will be too successful in converting doctors, who often find drugs are a convenient crutch when they lack the time or skill to dig into the roots of a problem. For big pharma, this means more profit from over-prescription.  https://t.co/8Uf0OdCRxj  https://t.co/SwCcON0Vq0